Ethics Case 1 Remonte. Rivera, K., Sagayaga. Siy. Talan.

Slides:



Advertisements
Similar presentations
Professional Education Support Wyeth Pharmaceuticals Melinda Somasekhar, PhD.
Advertisements

Social Initiative an Important tool for the pharmaceutical companies By: Prof M H Lakdawala.
Continuing Professional Development Conflict of Interest This presentation has been developed by the COI Working Group to assist in the implementation.
INTRODUCTION TO ETHICS IN PHARMACY PRACTICE PHCL 437
PHARMACIST CODE OF ETHICS
Integrating Ethics Into Your Compliance Program John A. Gallagher, Ph.D Center for Ethics in Health Care Atlanta, GA.
ETHICS ETHICS. ETHICS SEEKS TO DETERMINE WHAT A PERSON SHOULD DO, OR THE BEST COURSE OF ACTION, AND PROVIDES REASONS WHY. IT ALSO HELPS PEOPLE DECIDE.
Conflict of Interest in Physician-Industry Relationships
Merck and River Blindness
Introduction to basic principles
Canadian Nurse Practitioners and Pharmaceutical Influences
CPME Comité Permanent des Médecins Européens Standing Committee of European Doctors Doctors and industry - European perspective International.
Ethical and Legal Implications of Practice Chapter 5.
DOCTOR / DOCTOR AND DOCTOR PATIENT RELATIONSHIPS Idara C.E,
Promotion, professional practice and patient trust July 2014 Tim Reed Health Action International This document arises from HAI Europe’s Operating Grant.
Pharmaceutical Sales representatives July 2014 Tim Reed Health Action International This document arises from HAI Europe’s Operating Grant 2014, which.
Conflict of Interest. Definition  “A conflict of interest is a situation in which financial or other personal considerations have the potential to compromise.
How Doctors Think – Jerome Groopman, MD Chapter 9. Marketing, Money, and Medical Decisions Chapter 10. In Service of the Soul Melanie Swan MS Futures Group.
Chapter 14 Promoting Products.
Disputing Distribution: Ethics and Pharmaceuticals in Nepal Nabin Rawal, Ian Harper and Madhusudan Subedi.
# Operating Under the New Compliance Environment: Considerations for the Pharmaceutical Industry The Impact of the new Medicare Prescription Drug benefit.
Medicines Transparency Alliance05/09/2015 Medicine Promotion Robert Louie P. So, MD Program Manager DOH - National Center for Pharmaceutical Access and.
THE ORTHOPAEDIC SURGEON’S RELATIONSHIPS WITH INDUSTRY AAOS ETHICS COMMITTEE Kenneth C. Thomas, MD 1.
Role of Industry in Clinical Care, Research and Education Rev 10/21/2014 APGO Interaction with Industry: A Medical Student Guide.
New Staff Orientation: Industry Relations Emory School of Medicine Zainab R. Wurie, JD July 15, 2014.
Purchasing Ethics and Vendor Relations
1-1Copyright © Houghton Mifflin Company Business Ethics Ethical Decision Making and Cases 4 th Edition Ferrell, Fraedrich, Ferrell Yousef Y. Alyazji (MBA)
“Delivering Therapeutic Agents” - Marketing and Communication Strategies of Drug Companies Safura Nantogmah.
Case Study: Medical Research Jillian Cudmore Mallory Anne Andrea Currie Amy DeBaie.
+ Conflict of Interest in Physician-Industry Relationships.
ACCREDITATION CRITERIA CONFLICT OF INTEREST CONTENT INTEGRITY.
Vendor Relations Policy. Why Is There A Policy? The Patient Protection and Affordable Care Act was signed into law March 23, The new law contains.
WEEK 7 ETHICS & SOCIAL RESPONSIBILITY Özge Can –
Bribery By Sveinn Eldon. A bribe is a payment for a service The service consists in a decision which is not made on its merits but made on the bribe (or.
BUSINESS ETHICS Why is Business Ethics important in Business.
+ Role of Industry in Clinical Care, Research, and Education.
Chapter 4 Ethics and Social Responsibility. MGMT 321 – Chapter 4 Ethics The inner-guiding moral principles, values, and beliefs that people use to decide.
 the study of the rightness or wrongness of human conduct.  In any situation involving two or more individuals, values may come into conflict and ethical.
Philosophy 223 Marketing and Vulnerability. Marketing and Manipulation Our analysis of advertising and autonomy suggested that directing advertising at.
Understanding and responding to pharmaceutical promotion: A practical guide  Americas  Europe  Western Pacific  Eastern Mediterranean  Africa  South-East.
The Physician - Pharma Relationship.  Is very old and very close  But are the goals of pharmaceutical companies and medicine the same?
RESPONSIBILITY OF PHYSICIANS
Business Ethics “doing well by doing good”
By: Nicole Giardina. History of AMA AMA was founded on May 7, 1847 by Nathan Smith Davis. The meeting to create the AMA was held in the Academy of Natural.
Unit: Ethical and Legal.   Client Autonomy  The right of patients to make decisions about their medical care without their health care provider trying.
Japan Fair Competition Code for Medical Devices Industry (JFCC-MDI)
Compliance Issues in Dealing With Drug and Device Manufacturers Presentation to The Sixth Annual National Congress On Health Care Compliance Paul E. Kalb,
BUILDING THE BEST RELATIONSHIP WITH YOUR CLINIC/HEALTH CARE PROVIDERS 1.
ETHICAL ISSUES OF ADVERTISING IN HEALTHCARE.  Ethics is a code of behavior that specifies appropriate moral stances, particularly in professional dealings.
1 The Care Act Implications for housing with care Lorraine Jackson Sarah Cromwell.
Deontological Approaches Consequences of decisions are not always the most important elements as suggested by the consequentialist approach. The way you.
Given the progress that continues to be made in society’s battle against disease, patients are seeking more information about medical problems and potential.
Business Ethics & Ethical Decision Making. Principles & Standards  It guides the individual’s group behavior in the world of business.  Stakeholders.
Introduction 2. Pharmaceutical care is a professional patient care practice, which, when provided as an organized service, is experienced, documented,
From Jan 1, no freebies for docs from pharma firms.
DOCTOR / DOCTOR AND DOCTOR PATIENT RELATIONSHIPS Idara C.E,
Customer Satisfaction Doctors’ Arm Perceptual Mapping Tracker
Preventing Corruption & Bribery - Perspectives from the Regulators-
The IVD Australia Code of Conduct Edition 2.1
Disclosure UK Talking about Transparency.
Prescribing.
Ethics in pharmacy practice
Disclosure UK Talking about Transparency.
بنام خداوند جان و خرد كزين برتر انديشه بر نگذرد
Pharmacy practice experience I
Industry Induction Course
Dr. Aamir Shaikh Founder, Assansa India
Ethics.
Updates to the PhRMA Code on Interactions with Healthcare Professionals National Pharma Audioconference August 5, 2008.
Presentation transcript:

Ethics Case 1 Remonte. Rivera, K., Sagayaga. Siy. Talan.

Case Its Saturday lunch time, three medical clerks were just relieved of their duties and were about to go home when they saw a pharmaceutical company setting up a long table. They were invited to try some pizza and get free supplies of penlights, bags, pens, notebooks, while they listened to the sales representative telling them about a new drug. One of the medical clerks was even invited to join a grant sponsored by the company so he can attend a conference in Paris. After hearing about this, the dean of the college started considering banning all pharmaceutical industry-promoted activities to prevent prescribing bias.

1. What is the main dilemma/conflict or core issue involved in the case? Whether or not medical practitioners (students or doctors) should accept gifts or favors from pharmaceutical companies, and whether these benefits affect physicians’ prescribing behavior

2. Who are the parties who will be affected by the decision, both directly and indirectly? Physicians Evidence to show that relationships with drug companies influence prescribing behavior Contact with drug company representatives leads to prescribing of their drugs 1 physicians exposed to advertising are more likely to accept commercial rather than well established scientific views 2 drug company advertising is associated with an inability of some physicians to identify erroneous claims and propensity to engage in non- rational prescribing behaviour Peay MY, Peay ER. The role of commercial sources in the adoption of a new drug. Soc Sci Med 1988; 26: Lexchin J. Interactions between physicians and pharmaceutical industry. CMAJ 1993; 149: Haayer F. Rational prescribing and sources of information. Soc Sci Med 1982; 16:

2. Who are the parties who will be affected by the decision, both directly and indirectly? Physicians Duality of interests in doctors engaged in relationships with pharmaceutical companies

2. Who are the parties who will be affected by the decision, both directly and indirectly? Patients Primary stakeholder in health care Directly affected by physicians’ prescribing behavior The drugs they receive may not be the drugs best supported by evidence Example: Free samples may be given to patients Once the supply runs out, patients may not be shifted to other, less expensive drugs

2. Who are the parties who will be affected by the decision, both directly and indirectly? Shareholder/pharmaceutical company Great contributors to medical knowledge and practice, at the high cost of drug development Promotion and marketing make up a large part of drug companies’ activities 1/4 – 1/3 of budgets, totaling more than US$11 each year in the US

3. What are the key values involved? Distributive justice Benefits should accrue to those who bear the burden: physicians should not benefit from the patients’ payments for drugs Fiduciary trust/benevolence Physicians should act in the patient’s best interest (an external influence affecting the physicians’ actions may violate this principle) Balance of self-interest and altruism

4. How can you best resolve this situation? You may have several options to resolve the case. Cite some ethical principles that may guide your decision-making process. Various levels of advice have been advanced to medical practitioners about accepting gifts. blanket rejection gradient of moral acceptability based on cost gifts should not be excessive and should not influence decision- making test of whether the recipient would be willing to have the arrangements publicly known